Investment trust insider on Henderson Alternative Strategies James Carthew: ‘bargain’ trust poses too many questions For a discount player, there are very few pockets of real value in the investment companies market today. Boards are much better at controlling discounts and the search for income means that very few funds with a yield are on […]
Investment Trust Insider on Augmentum Fintech James Carthew: Augmentum’s mature focus stands out I regularly moan that the UK market is not very good at financing early stage British businesses. However, in March this year, we saw the launch of a new fund dedicated to supporting the burgeoning fintech industry in the UK, Augmentum Fintech (AUGM). The fund is […]
Investment Trust Insider on Cuba James Carthew: classic closed-end chance in Cuban property One of the great things about the investment companies sector is that it is always evolving. The closed-end structure is the ideal vehicle for an incredibly diverse range of assets as is demonstrated by the upcoming London listing of a Cuba property […]
After months of volatility, investment trusts in the biotech and commodity sectors were the winners in July in both price and NAV terms, according to latest figures. In its monthly investment companies round-up, trust analysts QuotedData revealed biotech and commodity investment trusts – which have had a difficult time over the last few months in […]
Investment Trust Insider on Syncona James Carthew: the problem with Syncona’s big premium Regular readers of this column will have realised that I often have as much of a problem with investment trusts trading on very high premiums as I do with trusts trading on very wide discounts. I explained a couple of weeks ago […]
Investment Trust Insider on Riverstone Energy James Carthew: Riverstone’s history restricts oil boom effect BP’s announcement on Friday that it is spending $10.5 billion to buy BHP’s US shale oil investments, comprising considerable acreage in the Permian and Eagle Ford basins plus gas-producing fields in the southern states of the US, is a good cue […]
Investment Trust Insider on how to grow trusts James Carthew: imponderable questions in quest for scale Last week I addressed the uphill battle Ashoka India Equity (AIE) faces if it wants to expand, having raised just £46.5 million in its flotation. It is by no means the smallest fund out there, however. Many of the […]
Investment Trust Insider on recent new issues – James Carthew: can Ashoka overcome a disappointing launch? It has been a week of contrasts in the new issue market. Tritax EuroBox (EBOX) raised its maximum target of £300 million in an issue that was ‘significantly oversubscribed’ and Hipgnosis Songs Fund (SONG) raised over £200 million. Whereas […]
Investment Trust Insider on Hadrian’s Wall Secured Lending James Carthew: Can Hadrian’s Wall take on Funding Circle? Funding Circle SME Income Fund (FCIF)’s premium has taken a bit of a knock after its board indicated that its dividend will be cut later this year. The fund had paid quarterly dividends at a run rate of […]
Investment Trust Insider on BlackRock Emerging Europe James Carthew: BlackRock trust could have avoided upset There have been some fun and games in the investment trust sector recently, what with the ongoing dispute between Invesco Perpetual Enhanced Income (IPE) and its former manager, the proposed merger of Dunedin Smaller Companies (DNDL) and Standard Life UK […]
